Harbour Biomed (guangzhou) Co. Ltd.

This study tested a weekly injection called HBM9161 in 36 adults with primary immune thrombocytopenia (ITP), a condition where the immune system destroys platelets, raising bleeding risk. The goal was to find the best dose and see if it safely increases platelet counts. Participa…

This study looked at the long-term safety of a drug called HBM9161 for people with generalized myasthenia gravis, a condition that causes muscle weakness. A total of 111 patients who had already completed an earlier study took part. The goal was to see if the drug is safe to use …

This study tested an eye drop called HBM9036 in 577 Chinese adults with moderate to severe dry eye. Participants used the drops or a placebo for about two months. The goal was to see if the drops improve eye surface health and reduce symptoms better than placebo.

This early-stage study tested a single injection of an experimental drug called HBM9378 in 50 healthy Chinese adults to see if it is safe and how the body processes it. The goal was not to treat asthma but to gather important safety and drug-level information for future studies. …